Robert Casey actually said...

The monetary loss to elder fraud and abuse is roughly $2.9 billion each year, and it is growing.

Pharmaceutical companies typically justify drug price increases... by expenditures such as research and development of the drug itself or a ...

Well, you should not have that uncertainty, especially in light of what you have already been through.

The question I have is, what factors went into the conclusion that Daraprim was undervalued?